共 41 条
- [31] The case for addressing primary resistance mutations to non-nucleoside reverse transcriptase inhibitors to treat children born from mothers living with HIV in sub-Saharan AfricaJOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2014, 17Kebe, KhadyBelec, LaurentNdiaye, Halimatou DiopGueye, Sokhna BoussoDiouara, Abou Abdallah MalickNgom, SafietouGueye, Ndeye Rama DiagneMbaye, NgagneSy, Haby SignateMboup, SouleymaneKane, Coumba Toure
- [32] The design and synthesis of diaryl ether second generation HIV-1 non-nucleoside reverse transcriptase inhibitors (NNRTIs) with enhanced potency versus key clinical mutationsBIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (09) : 2959 - 2966Tucker, Thomas J.Saggar, SandeepSisko, John T.Tynebor, Robert M.Williams, Theresa M.Felock, Peter J.Flynn, Jessica A.Lai, Ming-TainLiang, YuexiaMcGaughey, GeorgiaLiu, MeiquingMiller, MikeMoyer, GregoryMunshi, VandnaPerlow-Poehnelt, RebeccaPrasad, SridharSanchez, RosaTorrent, MaricelVacca, Joseph P.Wan, Bang-LinYan, Youwei
- [33] N2-Benzyloxycarbonylguan-9-yl acetic acid derivatives as HIV-1 reverse transcriptase non-nucleoside inhibitors with decreased loss of potency against common drug-resistance mutations.CHEMMEDCHEM, 2007, 2 (10) : 1405 - 1409Adebambo, Kassim F.Zanoli, SamanthaThomas, Michael G.Cancio, ReynelHowarth, Nicola M.Maga, Giovanni
- [34] Escaping from Flatland: Multiparameter Optimization Leads to the Discovery of Novel Tetrahydropyrido[4,3-d]pyrimidine Derivatives as Human Immunodeficiency Virus-1 Non-nucleoside Reverse Transcriptase Inhibitors with Superior Antiviral Activities against Non-nucleoside Reverse Transcriptase Inhibitor-Resistant Variants and Favorable Drug-like ProfilesJOURNAL OF MEDICINAL CHEMISTRY, 2023, 66 (13) : 8643 - 8665Wang, ZhaoSharma, Prem PrakashRathi, BrijeshXie, MinghuiDe Clercq, ErikPannecouque, ChristopheKang, DongweiZhan, PengLiu, Xinyong
- [35] Prevalence and quantitative phenotypic resistance patterns of specific nucleoside analogue mutation combinations and of mutations 44 and 118 in reverse transcriptase in a large dataset of recent HIV-1 clinical isolatesANTIVIRAL THERAPY, 2003, 8 (03) : U47 - U47Van Houtte, MLecocq, PBacheler, L
- [36] Simple, short peptide derivatives of a sulfonylindolecarboxamide (L-737,126) active in vitro against HIV-1 wild type and variants carrying non-nucleoside reverse transcriptase inhibitor resistance mutationsJOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (15) : 3892 - 3896Silvestri, RArtico, MDe Martino, GLLa Regina, GLoddo, RLa Colla, MLa Colla, P
- [37] R1206, a representative of a new class of potent diphenylether non-nucleoside reverse transcriptase inhibitors broadly active against NNRTI resistant HIV-1 variants and achieving high systemic exposures and benign safety profiles in animal speciesANTIVIRAL THERAPY, 2007, 12 (05) : S30 - S30Klumpp, K.Dunn, J.Heilek, G.Zhou, A.Stefanidis, D.Chen, C-WXu, J. B.Hang, J.Martin, M.Davidson, J.Harris, S.Mirzadegan, T.Paul, A.Li, Y.Su, G.Silva, T.Hirschfeld, D.Han, X.Swallow, S.Cammack, N.Vora, H.Hogg, H.Sweeney, Z.
- [38] R1206, a representative of a new class of potent diphenylether non-nucleoside reverse transcriptase inhibitors broadly active against NNRTI resistant HIV-1 variants and achieving high systemic exposures and benign safety profiles in animal speciesANTIVIRAL THERAPY, 2007, 12 : S30 - S30Klumpp, K.Dunn, J.Heilek, G.Zhou, A.Stefanidis, D.Chen, C-WXu, J. B.Hang, J.Martin, M.Davidson, J.Harris, S.Mirzadegan, T.Paul, A.Li, Y.Su, G.Silva, T.Hirschfeld, D.Han, X.Swallow, S.Cammack, N.Vora, H.Hogg, H.Sweeney, Z.
- [39] Structure-Based Optimization of Thiophene[3,2-d]pyrimidine Derivatives as Potent HIV-1 Non-nucleoside Reverse Transcriptase Inhibitors with Improved Potency against Resistance-Associated VariantsJOURNAL OF MEDICINAL CHEMISTRY, 2017, 60 (10) : 4424 - 4443Kang, DongweiFang, ZengjunHuang, BoshiLu, XueyiZhang, HengXu, HaoranHuo, ZhipengZhou, ZhongxiaYu, ZhaoMeng, QingWu, GaochanDing, XiaoTian, YeDaelemans, DirkDe Clercq, ErikPannecouque, ChristopheZhan, PengLiu, Xinyong
- [40] Design, Synthesis, and Biological Evaluation of 1-[(2-Benzyloxyl/alkoxyl)methyl]-5-halo-6-aryluracils as Potent HIV-1 Non-nucleoside Reverse Transcriptase Inhibitors with an Improved Drug Resistance ProfileJOURNAL OF MEDICINAL CHEMISTRY, 2012, 55 (05) : 2242 - 2250Wang, XiaoweiZhang, JianfangHuang, YangWang, RuipingZhang, LiangQiao, KangLi, LiLiu, ChangOuyang, YaboXu, WeisiZhang, ZhiliZhang, LiangrenShao, YimingJiang, ShiboMa, LiyingLiu, Junyi